ClinicalTrials.gg
CompletedNCT07672548RCTUpdated Nov 4, 2026

The Effects of 10-weeks Pilates Exercise on Pulmonary Function and Quality of Life in Postmenopausal Women

An interventional study of pilates exercises and diaphragmatic breathing exercises in Post Menopausal, sponsored by Middle East University. Completed at 1 site in Egypt. Open to female participants aged 50 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Middle East University · Not applicable, Interventional, and Treatment

Updated Nov 4, 2026Now CompletedFirst site in Egypt+7 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
50 Years to 60 Years
Sex
Female
01

Study summary

This study will investigate the effect of 10-weeks Pilates exercise on pulmonary function and quality of life in postmenopausal women with normal Body mass index

Read the detailed description

This study is significant because it explores a safe, low-impact, and accessible exercise method that may improve respiratory function and overall quality of life in postmenopausal women. Pilates emphasizes breathing, core strength, and controlled movements, which may be particularly beneficial for women experiencing age-related declines in lung function and physical well-being. The findings can support evidence-based exercise recommendations, promote non-pharmacological interventions, and contribute to improving the health and daily functioning of postmenopausal women.

02

Conditions studied

  • Post Menopausal
03

In context

Lead sponsor

Middle East University is the lead sponsor of 19 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women aged 50-60 years.
  • Women who suffered from breathing problems
  • Women with normal (BMI) 18 to 25 kg/m².
  • Women not related to any other studies.

Exclusion criteria

Exclusion Criteria:

  • Comorbidities such as cardiac or chest diseases (critically ill patients).
  • Receiving hormone replacement therapy.
  • ˃ 25 kg/m² or ˂ 18 kg/m²,
  • Age greater than 60 years or less than 50 years,
  • Use of sedatives, tranquilizers, or antidepressant medications,
  • Musculoskeletal disorders.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    control group

    It will consist of 15 postmenopausal women. They will receive diaphragmatic breathing exercises for 5 to 10 minutes in a session, about 3-4 times per day and follow up after 10 weeks

    Other: diaphragmatic breathing exercises

  • Experimental
    study group

    It will consist of 15 postmenopausal women. They will receive diaphragmatic breathing exercises for 5 to 10 minutes in a session, about 3-4 times per day for 10 weeks in addition to pilates exercise for 50-minute per s session for 5 times per week and follow up after 10 weeks

    Other: pilates exercises · Other: diaphragmatic breathing exercises

Interventions

  • Otherpilates exercises

    low-impact exercise method that focuses on strengthening muscles while improving posture, flexibility, and overall body alignment. It emphasizes controlled movements, proper breathing, and core strength (especially the abdomen, lower back, hips, and pelvis).for 50-minute pers session for 5 times per week and follow up after 10 weeks

  • Otherdiaphragmatic breathing exercises

    is a technique that focuses on deep breathing using the diaphragm rather than shallow chest breaths. It helps improve oxygen intake and promotes relaxation.for 5 to 10 minutes in a session, about 3-4 times per day and follow up after 10 weeks

06

What researchers measure

Primary outcomes

  1. Forced Vital Capacity

    will be recorded before and after the intervention using a spirometer, and measured in liters

    Time frame: 10 weeks

  2. Forced Expiratory Volume

    will be recorded before and after the intervention using a spirometer, and measured in liters

    Time frame: 10 weeks

  3. Peak Expiratory Flow Rate and measured in liters per seconds

    will be recorded before and after the intervention using a spirometer, and measured in liters

    Time frame: 10 weeks

Secondary outcomes

  1. Quality of life questionnaire :

    SF-12 Health Survey will be used for the assessment of quality of life. It is a brief, 12-question covering eight health domains, including physical functioning, mental health, Score range: Lowest: 0 Highest: 100 Interpretation: 0 = worst health status 100 = best health status pain, and social functioning, yielding Physical (PCS) and Mental (MCS) Component Summary scores

    Time frame: 10 weeks

07

Study locations

1 site
  • Ayman Mohammad Abu Elmila Mahany
    Damietta, 11829., Egypt
08

References and documents

Individual participant data

Plan to share: No — No IPD Sharing

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Nov 4, 2026
Sites
1 site added, 1 site removed — first site in Egypt; no longer in Jordan
Show site
  • Ayman Mohammad Abu Elmila Mahany · Damietta, Egypt
Show 1 removed
  • Ayman Mohammad Abu Elmila Mahany · Amman, Jordan
Nov 4, 2026
Start date
Jun 1, 2026→Jul 1, 2026
Nov 4, 2026
Primary completion
Jul 1, 2026→Oct 10, 2026 (actual)
Nov 4, 2026
Study completion
Oct 1, 2026→Oct 30, 2026 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Completed
    1 site added, 1 site removed — first site in Egypt; no longer in Jordan
    Show site
    • Ayman Mohammad Abu Elmila Mahany · Damietta, Egypt
    Show 1 removed
    • Ayman Mohammad Abu Elmila Mahany · Amman, Jordan
    Start date Jun 1, 2026→Jul 1, 2026
    Primary completion Jul 1, 2026→Oct 10, 2026 (now actual)
    Study completion Oct 1, 2026→Oct 30, 2026 (now actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07672548
Lead sponsor
Middle East University
Responsible party
Ayman Mohammad Abu Elmila Mahany (Assisstant professor of physical therapy, Horus University) — Principal investigator
First posted
Jun 29, 2026
Start date
Jul 1, 2026
Primary completion
Oct 10, 2026
Completion
Oct 30, 2026
Last update
Nov 4, 2026

Study contacts

Ayman Mahany
principal investigator · Horus University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion